Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps
NCT04157335Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Nov 2019
- Primary completion
- Aug 2024
- Countries
- 17
01
Overview
A Phase 3 trial of benralizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by AstraZeneca. Started Nov 2019; status: terminated.
02
Drugs
benralizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT04157335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04157335.